Amicus Therapeutics, Inc. (FOLD)

NASDAQ

$--

(--)

After-Hours

Amicus Therapeutics, Inc. (FOLD) Live Price Chart

Last updated: ⁦2026-10-15 23:21:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Amicus Therapeutics, Inc. (FOLD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Amicus Therapeutics, Inc. (FOLD) After-Hours Stock Price

Amicus Therapeutics, Inc. (FOLD) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.

After-hours trading shows how investors are pricing FOLD after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.

Amicus Therapeutics, Inc. (FOLD) 7-Day Stock Price Change

Over the past seven days, Amicus Therapeutics, Inc. (FOLD) moved from $14.45 to $14.49, representing a gain of 0.28% ($0.04).

The stock traded between $14.45 and $14.50 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 2.79 million shares, down versus the previous seven-day period, indicating lower trading activity.

What is Amicus Therapeutics, Inc. (FOLD)?

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Amicus Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	511
Exchange	NASDAQ
Company Website	https://www.amicusrx.com

How to Buy Amicus Therapeutics, Inc. (FOLD) Stock on MEXC

Eligible investors can buy real shares of Amicus Therapeutics, Inc. (FOLD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FOLD and Place Your Order

Open the RealStocks trading page and search for FOLD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Amicus Therapeutics, Inc. (FOLD) stock price today?

Amicus Therapeutics, Inc. (FOLD) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is FOLD stock going up or down today?

As of --, FOLD is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is FOLD pre-market price?

As of --, FOLD is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FOLD after-hours price?

As of --, FOLD is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FOLD stock trading now?

FOLD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FOLD sit relative to its 52-week high and low?

Over the past 52 weeks, FOLD has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Amicus Therapeutics, Inc. in?

Amicus Therapeutics, Inc. (FOLD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Amicus Therapeutics, Inc.'s market capitalisation and where is it listed?

Amicus Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FOLD valued in terms of P/E ratio and EPS?

FOLD trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Amicus Therapeutics, Inc. pay a dividend?

Amicus Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.